Structuring of a Lung Cancer Screening Program Including Clinical, Radiological and Biological Phenotyping Useful for the Development of Individualized Risk Prediction Tools: PREVALUNG ETOILE
Conditions:   Smoking-related Pathology;   Atheroma;   Chronic Bronchitis;   Non-progressive Cancer > 5 Years;   Lung Cancer Interventions:   Device: thoracic scan Low dose;   Biological: BLOOD SAMPLE;   Biological: FECES SAMPLE Sponsor:   Assistance Publique Hopitaux De Marseille Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 13, 2022 Category: Research Source Type: clinical trials